Rivaroxaban Impurity 20 | CAS 6310-09-4 - Request Quote
Rivaroxaban Impurity 20
| SZ CAT No: | SZ-R017043 |
| CAS No | 6310-09-4 |
| Mol.F. | C6H5ClOS |
| Mol.Wt. | 160.6 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 20 is chemically 1-(5-chlorothiophen-2-yl)ethan-1-one. Rivaroxaban Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 6310-09-4
Purchase 6310-09-4
Order 6310-09-4
Enquire 6310-09-4
price of 6310-09-4
6310-09-4 Supplier
6310-09-4 Manufacturer
6310-09-4 Exporter
buy high quality Rivaroxaban Impurity 20
Purchase Rivaroxaban Impurity 20
Rivaroxaban Impurity 20 suppliers
Rivaroxaban Impurity 20 manufacturers
Rivaroxaban Impurity 20 price
Order Rivaroxaban Impurity 20
Enquire Rivaroxaban Impurity 20
Rivaroxaban Impurity 20 cost
Rivaroxaban Impurity 20 Supplier
Rivaroxaban Impurity 20 Distributor
Rivaroxaban Impurity 20 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 20 for ANDA Filing
Rivaroxaban Impurity 20 for Forced Degradation Studies
Rivaroxaban Impurity 20 Identification Standards
Rivaroxaban Impurity 20 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


